Takahiro Shimo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Takahiro Shimo has a total of 51 co-authors. Here are the top co-authors by number of shared publications:
- Akihiro Yamano
Department of Medical Physics, Shonan Kamakura General Hospital, 1370-1 Okamoto, Kamakura City, Kanagawa 247-8533, Japan
3 shared publications Masashi Yamanaka
Department of Medical Physics Shonan Kamakura General Hospital Kamakura Kanagawa Japan
3 shared publicationsKazuki Matsumoto
Department of Medical Physics, Shonan Kamakura General Hospital, 1370-1 Okamoto, Kamakura City, Kanagawa 247-8533, Japan
2 shared publications- Masashi Yamanaka
Department of Medical Physics, Shonan Kamakura General Hospital, Kamakura, Japan;
2 shared publications Shintaro Shiba
Department of Radiation Oncology, Shonan Kamakura General Hospital, Kamakura City, Japan
2 shared publicationsAkihiro Yamano
Department of Medical Physics, Shonan Kamakura General Hospital, Kamakura City, Japan
1 shared publication
Latest Publications
- 11 September 2026
- Published by Elsevier in Physica Medica
- Vol. 150
Preliminary investigation of iodine-doped MR-based polymer gel dosimeter for fiducial-free tumour-tracking radiotherapy
- 11 September 2026
- Published by Elsevier in Physica Medica
- Vol. 150
Preliminary investigation of iodine-doped MR-based polymer gel dosimeter for fiducial-free tumour-tracking radiotherapy
- 22 March 2026
- Published by Elsevier in Physica Medica
- Vol. 145, 105786
Evaluation of patient-specific quality assurance tolerances based on statistical process control in pencil beam scanning proton therapy
- 22 March 2026
- Published by Elsevier in Physica Medica
- Vol. 145, 105786
Evaluation of patient-specific quality assurance tolerances based on statistical process control in pencil beam scanning proton therapy
- Open Access
- 29 December 2025
- Published by Wiley in Journal of Applied Clinical Medical Physics
- Vol. 27 (1) , e70453
Proton stereotactic body radiotherapy for early‐stage non‐small cell lung cancer: Influence of case‐specific characteristics on dosimetric robustness
Background and purpose: Proton stereotactic body radiotherapy (SBRT) offers superior dose conformity. However, its clinical application remains limited due to uncertainties from setup errors and respiratory motion. This study quantified the dosimetric robustness of proton SBRT for early‐stage non‐small cell lung cancer under combined setup and interplay uncertainties and investigated the association between dosimetric robustness and case‐specific characteristics. Methods: Robust proton SBRT plans were generated considering setup and range uncertainties. Dosimetric robustness was evaluated by comparing the clinical target volume (CTV) coverage indices (V95%, V98%, and V100%) between the nominal condition and conditions incorporating combined setup and interplay uncertainties. The influence of respiratory amplitude, tumor volume, and mean tumor CT value on dosimetric robustness was assessed. Results: CTV coverage remained stable under nominal conditions. However, dose degradation occurred under combined setup and interplay uncertainties, with the median CTV V100% decreased below 70%. Larger respiratory amplitudes and lower mean tumor CT values were associated with reduced dosimetric robustness. Conclusions: Combined uncertainties significantly affected the dosimetric robustness of proton SBRT depending on case‐specific characteristics. Our exploratory analysis indicates the potential need for individualized robustness strategies in proton SBRT planning.
- 29 December 2025
- Published by Wiley in Journal of Applied Clinical Medical Physics
- Vol. 27 (1) , e70453
Open AccessProton stereotactic body radiotherapy for early‐stage non‐small cell lung cancer: Influence of case‐specific characteristics on dosimetric robustness
Background and purpose: Proton stereotactic body radiotherapy (SBRT) offers superior dose conformity. However, its clinical application remains limited due to uncertainties from setup errors and respiratory motion. This study quantified the dosimetric robustness of proton SBRT for early‐stage non‐small cell lung cancer under combined setup and interplay uncertainties and investigated the association between dosimetric robustness and case‐specific characteristics. Methods: Robust proton SBRT plans were generated considering setup and range uncertainties. Dosimetric robustness was evaluated by comparing the clinical target volume (CTV) coverage indices (V95%, V98%, and V100%) between the nominal condition and conditions incorporating combined setup and interplay uncertainties. The influence of respiratory amplitude, tumor volume, and mean tumor CT value on dosimetric robustness was assessed. Results: CTV coverage remained stable under nominal conditions. However, dose degradation occurred under combined setup and interplay uncertainties, with the median CTV V100% decreased below 70%. Larger respiratory amplitudes and lower mean tumor CT values were associated with reduced dosimetric robustness. Conclusions: Combined uncertainties significantly affected the dosimetric robustness of proton SBRT depending on case‐specific characteristics. Our exploratory analysis indicates the potential need for individualized robustness strategies in proton SBRT planning.
- Open Access
- 17 June 2025
- Published by MDPI AG in Applied Sciences
- Vol. 15 (12) , 6833
Investigating the Secondary Thermal Neutron Intensity of Neutron Capture-Enhanced Proton Therapy
This study aimed to investigate the distribution of thermal neutron fluence generated during proton-beam therapy (PBT) scanning, focusing on neutrons produced within the body using Monte Carlo simulations (MCSs). MCSs used the Particle and Heavy Ion Treatment Code System to define a 35 × 35 × 35 cm3 water phantom, and proton-beam energies ranging from 70.2 to 228.7 MeV were investigated. The MCS results were compared with neutron fluence measurements obtained from gold activation analysis, showing good agreement with a difference of 3.54%. The internal thermal neutron distribution generated by PBT was isotropic around the proton-beam axis, with the Bragg peak depth varying between 3.45 and 31.9 cm, while the thermal neutron peak depth ranged from 5.41 to 15.9 cm. Thermal neutron generation depended on proton-beam energy, irradiated particle count, and depth. Particularly, the peak of the thermal neutron fluence did not occur within the treatment target volume but in a location outside the target, closer to the source. This discrepancy between the Bragg peak and the thermal neutron fluence peak is a key finding of this study. These data are crucial for optimizing beam angles to maximize dose enhancement within the target during clinical applications of neutron capture-enhanced particle therapy.
- 17 June 2025
- Published by MDPI AG in Applied Sciences
- Vol. 15 (12) , 6833
Open AccessInvestigating the Secondary Thermal Neutron Intensity of Neutron Capture-Enhanced Proton Therapy
This study aimed to investigate the distribution of thermal neutron fluence generated during proton-beam therapy (PBT) scanning, focusing on neutrons produced within the body using Monte Carlo simulations (MCSs). MCSs used the Particle and Heavy Ion Treatment Code System to define a 35 × 35 × 35 cm3 water phantom, and proton-beam energies ranging from 70.2 to 228.7 MeV were investigated. The MCS results were compared with neutron fluence measurements obtained from gold activation analysis, showing good agreement with a difference of 3.54%. The internal thermal neutron distribution generated by PBT was isotropic around the proton-beam axis, with the Bragg peak depth varying between 3.45 and 31.9 cm, while the thermal neutron peak depth ranged from 5.41 to 15.9 cm. Thermal neutron generation depended on proton-beam energy, irradiated particle count, and depth. Particularly, the peak of the thermal neutron fluence did not occur within the treatment target volume but in a location outside the target, closer to the source. This discrepancy between the Bragg peak and the thermal neutron fluence peak is a key finding of this study. These data are crucial for optimizing beam angles to maximize dose enhancement within the target during clinical applications of neutron capture-enhanced particle therapy.
- Open Access
- 1 January 2025
- Published by Wolters Kluwer Health in Journal of Medical Physics
- Vol. 50 (1) , 14-19
Evaluation of the Mini-ridge Filter’s Impact on the Generation of Secondary Radiation in Synchrotron-based Proton Beam Therapy
Purpose: This study evaluated whether the mini-ridge filter (MRF) used for beam energy optimization in a synchrotron-based proton beam therapy (PBT) affects the generation of secondary neutrons and photons. Materials and Methods: Secondary radiation from the PBT was evaluated using a Monte Carlo simulation (MCS) with the Particle and Heavy-ion Transport code System (version 3.31), and the PROBEAT-M1 system (Hitachi, Japan) was modeled. In the analysis, we focused on the production of neutrons and photons in a 35 cm ×35 cm ×35 cm water phantom with and without MRF to ensure the accuracy of the dose calculation. Results: The MCS results were in good agreement with the measurement results, and the off-axis ratio at the center of the spread-out Bragg peak was 100% at a gamma analysis pass rate of 2 mm/2%. The photon fluence decreased by 4.0 and 0.9% at 70.2 and 228.7 MeV, respectively, but no significant effect on total neutron and photon production was observed (P > 0.05). The MRF effect on the dose was −1, suggesting that a clinically significant effect is negligible. Conclusions: These results demonstrated that MRF had a limited effect on the generation of secondary radiation in PBT. MRF, which is used to improve dose distribution, has the potential to be safely used without increasing secondary radiation, and MRF might not affected to generate secondary radiation to clinically meaningful levels.
- 1 January 2025
- Published by Wolters Kluwer Health in Journal of Medical Physics
- Vol. 50 (1) , 14-19
Open AccessEvaluation of the Mini-ridge Filter’s Impact on the Generation of Secondary Radiation in Synchrotron-based Proton Beam Therapy
Purpose: This study evaluated whether the mini-ridge filter (MRF) used for beam energy optimization in a synchrotron-based proton beam therapy (PBT) affects the generation of secondary neutrons and photons. Materials and Methods: Secondary radiation from the PBT was evaluated using a Monte Carlo simulation (MCS) with the Particle and Heavy-ion Transport code System (version 3.31), and the PROBEAT-M1 system (Hitachi, Japan) was modeled. In the analysis, we focused on the production of neutrons and photons in a 35 cm ×35 cm ×35 cm water phantom with and without MRF to ensure the accuracy of the dose calculation. Results: The MCS results were in good agreement with the measurement results, and the off-axis ratio at the center of the spread-out Bragg peak was 100% at a gamma analysis pass rate of 2 mm/2%. The photon fluence decreased by 4.0 and 0.9% at 70.2 and 228.7 MeV, respectively, but no significant effect on total neutron and photon production was observed (P > 0.05). The MRF effect on the dose was −1, suggesting that a clinically significant effect is negligible. Conclusions: These results demonstrated that MRF had a limited effect on the generation of secondary radiation in PBT. MRF, which is used to improve dose distribution, has the potential to be safely used without increasing secondary radiation, and MRF might not affected to generate secondary radiation to clinically meaningful levels.
- 14 May 2024
- Published by Elsevier in Nuclear Instruments and Methods in Physics Research Section A: Accelerators, Spectrometers, Detectors and Associated Equipment
- Vol. 1064
Developing and validating measurement methods combining 6LiF sintered capsule and Mg2SiO4: Tb (TLD-MSO-S) for -ray dose evaluation at accelerator-based BNCT system
- 14 May 2024
- Published by Elsevier in Nuclear Instruments and Methods in Physics Research Section A: Accelerators, Spectrometers, Detectors and Associated Equipment
- Vol. 1064
Developing and validating measurement methods combining 6LiF sintered capsule and Mg2SiO4: Tb (TLD-MSO-S) for -ray dose evaluation at accelerator-based BNCT system
- Open Access
- 19 July 2022
- Published by Archives of Breast Cancer in Archives of Breast Cancer
- p. 456-464
Impact of the Delineation Accuracy of Lumpectomy Cavity on Planning Target Volume in Partial-Breast Irradiation Using Brachytherapy and External-Beam Radiotherapy
Background: In partial-breast irradiation (PBI), the accurate target volume delineation based on the lumpectomy cavity (LC) remained difficult due to uncertain LC identification. However, the impact of accurate LC delineation on the planning target volume (PTV) has not been investigated. Materials and Methods: Between September 2018 and April 2020, 159 patients receiving perioperative PBI with multicather-interstitial brachytherapy have been evaluated. While LC delineated using implanted catheters as fiducial markers was used as a reference, conventional LC was virtually delineated on computed tomography with clips. PTV1-cm margin and PTV2-cm margin, which means 1cm and 2cm expansion from LC, were developed and assumed for brachytherapy and external-beam PBI, respectively. The target accuracy and the impact of the delineation accuracy of LC on PTVs were evaluated. The geographic miss index (GMI) and normal tissue index (NTI) were used as accuracy indices and were defined as the percentage of under- and overestimating volume, respectively. Results: The PTV1-cm margin and PTV2-cm margin were significantly larger than the reference volume, 57.9cm3 vs. 37.9cm3 (P<0.001) and 113.2cm3 vs. 93.8cm3 (P<0.001), respectively. The GMI and NTI of LC were 27.3% and 41.2%, respectively. Although the GMI in the PTV1-cm margin and PTV2-cm margin was significantly reduced to 9.8% (P<0.0001) and 9.9% (P<0.0001), respectively, the NTI was not significantly improved in the PTV1-cm margin, which was 41.8% (P=0.60) but was improved in PTV2-cm margin, which was 23.1% (P<0.0001). Conclusion: The GMI in PTV1-cm margin was reduced to be as low as PTV2-cm margin. Although PTV2-cm margin was associated with lower NTI, the absolute volume was almost double with PTV1-cm margin. Although further research was required, brachytherapy-based PBI may be a reasonable option to achieve tumor control and cosmesis using conventional delineation method.
- 19 July 2022
- Published by Archives of Breast Cancer in Archives of Breast Cancer
- p. 456-464
Open AccessImpact of the Delineation Accuracy of Lumpectomy Cavity on Planning Target Volume in Partial-Breast Irradiation Using Brachytherapy and External-Beam Radiotherapy
Background: In partial-breast irradiation (PBI), the accurate target volume delineation based on the lumpectomy cavity (LC) remained difficult due to uncertain LC identification. However, the impact of accurate LC delineation on the planning target volume (PTV) has not been investigated. Materials and Methods: Between September 2018 and April 2020, 159 patients receiving perioperative PBI with multicather-interstitial brachytherapy have been evaluated. While LC delineated using implanted catheters as fiducial markers was used as a reference, conventional LC was virtually delineated on computed tomography with clips. PTV1-cm margin and PTV2-cm margin, which means 1cm and 2cm expansion from LC, were developed and assumed for brachytherapy and external-beam PBI, respectively. The target accuracy and the impact of the delineation accuracy of LC on PTVs were evaluated. The geographic miss index (GMI) and normal tissue index (NTI) were used as accuracy indices and were defined as the percentage of under- and overestimating volume, respectively. Results: The PTV1-cm margin and PTV2-cm margin were significantly larger than the reference volume, 57.9cm3 vs. 37.9cm3 (P<0.001) and 113.2cm3 vs. 93.8cm3 (P<0.001), respectively. The GMI and NTI of LC were 27.3% and 41.2%, respectively. Although the GMI in the PTV1-cm margin and PTV2-cm margin was significantly reduced to 9.8% (P<0.0001) and 9.9% (P<0.0001), respectively, the NTI was not significantly improved in the PTV1-cm margin, which was 41.8% (P=0.60) but was improved in PTV2-cm margin, which was 23.1% (P<0.0001). Conclusion: The GMI in PTV1-cm margin was reduced to be as low as PTV2-cm margin. Although PTV2-cm margin was associated with lower NTI, the absolute volume was almost double with PTV1-cm margin. Although further research was required, brachytherapy-based PBI may be a reasonable option to achieve tumor control and cosmesis using conventional delineation method.